(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

As the 2025 midterm elections approach, a major change is on the horizon for the country’s election system. The Commission on Elections (Comelec) has decided to move ...